← Insider buys
RCUS

Arcus Biosciences, Inc. · Healthcare

COO Jennifer Jarrett sold $1.4M of Arcus Biosciences, Inc.

Sold$1,444,369
$41.48Price
34,822Shares
−28%Stake

What RCUS did after the filing

Filed Dec 22Copier in Dec 23
The stock from Thu, Dec 23 open, $41.94
−27.8%
S&P 500, same days
−4.6%

Measured over 30 trading days, to the Feb 7 close.

Traded Mon, Dec 20. Filed Wed, Dec 22, 5:03 PM ET, after the close. Returns use the Dec 23 open and the Feb 7 close. Not investment advice.